This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
News release. Federal Trade Commission. January 14, 2025. Accessed July 23, 2025. link] Rutledge, Attorney General of Arkansas v. Pharmaceutical Care Management Association, No.18–540. Accessed July 23, 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025. Accessed July 23, 2025.
Reduced immunity from COVID-19 precautions and low vaccination rates, especially among children and vulnerable groups, worsened the influenza season's impact. H3N2 is especially worrisome because of its frequent mutations, which can hinder immune recognition and response. 4 Immune response data showed that just 50.9%
Updated June 15, 2020. 9 If a situation warrants measurement of DOAC levels, such as a major bleeding event or concern about drug accumulation, the preferred test to quantify the anticoagulant effects would be anti–factor Xa activity calibrated specifically for the DOAC being measured. REFERENCES Rivaroxaban. MedlinePlus. link] Edoxaban.
2019;380:2020-2030. Global Initiative for Asthma. Accessed June 9, 2025. Beasley R, Holliday M, Reddell HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med.
Data collection spanned January 2020 to March 2023. This study examines herbal supplement prevalence, pharmacist interventions, and their impact on oncology treatment safety. Materials and Methods A survey-based observational study was conducted at the UC Davis Comprehensive Cancer Center.
Insani WN, Qonita NA, Jannah SS, et al. Improper disposal practice of unused and expired pharmaceutical products in Indonesian households. 2020;6(7):e04551. doi:10.1016/j.heliyon.2020.e04551 What to do with unwanted household medicines. United States Environmental Protection Agency. Updated March 28, 2025. Accessed June 6, 2025. Take Back Day.
August 19, 2020. SGLT-2 inhibitors – handout for patients. Duke University Nephrology. Accessed June 18, 2025. If you have diabetes, do you know about SADMANS? Drug Opinions. Accessed June 18, 2025.
Signal Transduction Targeted Therapy 2020; 5:101. HALO: results from a phase 2 double-blind, placebo-controlled trail evaluating the efficacy and safety of baxdrostat in patients with uncontrolled hypertension. Presented at ACC/WCC 2023. March 4, 2023. New Orleans. Hu B, Zhong L, Weng Y, et al. Therapeutic siRNA: state of the art.
The pharma struck a development deal for Datroway worth up to $1 billion up front in 2020 and has estimated its peak sales could reach $5 billion. pharma is facing potential headwinds as the FDA’s attitude toward immunizations shifts under new leadership. While Enhertu pulled in about $3.8 A long-time leader in vaccines, the U.K.
Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Arthritis Care Res ( Hoboken ). 2021;73(1):1-9.
In 2020, Mylan merged with Upjohn, Pfizer’s off-patent medicine division, to form Viatris. Find out more Mylan has since faced criticism for inflating the price of EpiPen and constraining patient access. The company has faced numerous lawsuits over the years in relation to overcharging drug wholesalers for access.
Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus. doi:10.1136/bmjdrc-2020-001248 5. Ibrahim M, Davies MJ, Ahmad E, et al. BMJ Open Diabetes Res Care. 2020;8(1):e001248. Chen M, Zhong VW.
Published Online May 19, 2020. Ganaie F, Saad JS, McGee L, et al. A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large cps Fragment from an Oral Streptococcus. Accessed July 31, 2025. doi:11:10.1128/mbio.00937-20.
trillion economic impact in 2020. trillion economic impact in 2020. trillion (about $4600 per capita in the US) in 2020. trillion in 2020. LIMITX technology, developed by Abuse Deterrent Pharma and Acura Pharmaceuticals, controls drug release to reduce overdose risk. It just might start saving lives. REFERENCES 1.
but below 2020 high. link] Flu vaccination coverage, United States, 2023-24 influenza season. September 20, 2024. Accessed June 10, 2025. link] FluVaxView. Accessed June 10, 2025. link] Brenan M. Nurses retain top ethics rating in U.S., January 10, 2023. Accessed June 10, 2025.
While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. 1991;68(3):499-501. doi:10.1002/1097-0142(19910801)68:3 3.0.co;2-f European Medicines Agency. Accessed July 21, 2025. link] NHS England.
The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. September 13, 2020. Trump to pitch sweeping Medicare drug price plan. May 7, 2025. Accessed May 13, 2025.
1 Population cohorts included adults ages 65 or older enrolled in Medicare and adults ages 19 to 64 years enrolled in Medicaid and deemed eligible for pneumococcal vaccination based on Advisory Committee on Immunization Practices recommendations. 1 Medicare enrollees were examined first. Last Updated October 4, 2024. Accessed July 23, 2025.
On February 21, 2020, the FDA approved eptinezumab-jjmr (Vyepti; Lundbeck) as the first intravenous migraine preventative treatment for adults. Pharmacists are essential in managing access, patient education, and monitoring outcomes, ensuring adherence and addressing administrative challenges.
The investigators conducted a retrospective study and gathered patient information from the hospital information system of Shenzhen Luohu People’s Hospital from May 1, 2020, to December 31, 2023. The primary study end point was the Humira retention rate at week 52, which was estimated through survival analysis. 0.92) and 0.44 (95% CI 0.34–0.52),
VMAT2 Inhibitors Updated in 2020, American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (Third Edition) and A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia recommend treatment with a VMAT2 inhibitor for patients with TD.
However, the clinical benefit of the use of immune checkpoint inhibitors (ICIs) and antiangiogenic agents for patients remains uncertain, highlighting an urgent need to develop new therapeutic strategies. The normalization of blood vessels using antiangiogenic agents may promote immune cell infiltration and change the tumor microenvironment.
Since launching Amazon Pharmacy in November of 2020, we've made it easier for patients to access low-priced medications and have them delivered to their door. Common barriers that I think of include access and cost, but also treatment complexity and forgetfulness.
These diseases are caused by a dysregulated mucosal immune response to the intestinal microflora in hosts who are genetically predisposed. 1 Interestingly, there were similar rates of biosimilar initiation by age group every year except for 2020 ( p =.03), 1 About 17.3%
In June 2020, the antibody gained approval from the US regulator for treating adults with aquaporin-4 immunoglobulin G positive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD). . Time to first treated and adjudicated IgG4-RD flare was the trials primary endpoint.
Contrastingly, during the pandemic years of 2020 and 2021, the hospitalization rate was significantly lower, at 2.3% Additionally, in all years excluding 2020, a significantly higher proportion of patients were not treated with antibiotics prior to their hospital admission. and 5.6%, respectively.
For a while, such stockpiling will leave the industry relatively immune to tariff actions, which have varied from week to week since the spring. This was an increase of 71% from February 2025, largely due to Trump’s tariffs,” which are yet to be imposed.
Updated May 6, 2020. link] Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry, January 2018. Accessed June 9, 2025. link] FDA Drug Shortages. Updated December 19, 2024. Accessed June 9, 2025.
Using data from the National Cancer Database, they performed a retrospective analysis on patients diagnosed with metastatic HR–/HER2+ breast cancer between January 2013 and December 2020. 031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). 3 Among the patients, approximately 75.8%
The total deal value of US licensing of innovator drug candidates from Chinese biopharma companies has surged 280% since 2020. By GlobalData Learn more about Strategic Intelligence South Korea joins China as a fast-growing destination for promising pipeline drug candidates.
AbbVie and Genmab partnered on the development of Epkinly in 2020. The therapy is a bispecific antibody that targets CD3 and CD20, redirecting and activating T-cells to CD20-expressing cancer B-cells.
Benefits for the Baby Human breast milk is nutrient-rich and contains a variety of anti-inflammatory, immune-protective, and antimicrobial properties that support your baby’s immune system and reduce the risk of lower respiratory tract infections, ear infections (otitis media), and gastroenteritis. What does the research say?
Treatment directed at eradicating the inhibitor Immune tolerance induction (ITI) involves the regular infusion of factor VIII to induce antigen-specific tolerance. Although not commonly used in ITI protocols, immune modulation can improve tolerance success. Agents such as cyclophosphamide, intravenous immune globulin, rituximab.
Treatment directed at eradicating the inhibitor Immune tolerance induction (ITI) involves the regular infusion of factor VIII to induce antigen-specific tolerance. Although not commonly used in ITI protocols, immune modulation can improve tolerance success. Agents such as cyclophosphamide, intravenous immune globulin, rituximab.
Cardiovascular Health, 2010 to 2020: A Systematic Review of a Decade of Research on Life's Simple 7. Cardiovascular Health Promotion in Children: Challenges and Opportunities for 2020 and Beyond: A Scientific Statement From the American Heart Association. 2 REFERENCES 1. Aguayo L, Cotoc C. doi.org/10.1161/JAHA.124.038566
PCMA unanimous Supreme Court decision in 2020, which allowed states to regulate PBMs, the big health insurance companies and their PBM lobby have been barnstorming the country putting up one legal challenge after another. Douglas Hoey on the U.S.
LaNova’s drug development focuses on tumour immunity and the tumour microenvironment. Licensing deals between US and Chinese biopharma companies hit record highs last year, a 280% increase from 2020, according to analysis by GlobalData. Sino revealed the acquisition agreement after trading hours on 15 July. by market close.
However, we are concerned about the proposed removal of five data elements from the Long-Term Care Hospital Continuity Assessment Record and Evaluation (LCDS), particularly those related to SDOH and immunization status. 8 (August 27, 2020): e2012569. Bekelman, and Jalpa A. JAMA Network Open 3, no.
Like many other biotechnology firms, it’s seen its stock price fall significantly during a sector-wide pullback, with shares losing more than three quarters of their value since 2020. Still, a deal Nuvation cut last year to acquire AnHeart Therapeutics has given it a chance to rebound. Track the deals that are happening here.
Tegoprubart’s mechanism of action targets the CD40L pathway, which plays a pivotal role in immune cell communication. since September 2020. This targeted approach offers several advantages over conventional immunosuppressants, which often cause significant side effects such as nephrotoxicity, hypertension, and diabetes.
Hedderich was named “Employee of the Year” by the Healthcare Council for the National Capital Area in 2020 for her exceptional service. Dr. Jarrett’s research experience has led to the publishing of his findings on the immune response in systemic lupus erythematosus, quality and cybersecurity in healthcare. Che Jordan, DHA.
mRNA technology was accelerated in 2020 due to the modality being central to all Covid vaccinations. According to a report from GlobalData , parent company of Pharmaceutical Technology , the value of mRNA licensing deals held 800% more value in 2024 than in 2019.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content